GB201907242D0 - Dna methods etc ii - Google Patents

Dna methods etc ii

Info

Publication number
GB201907242D0
GB201907242D0 GBGB1907242.0A GB201907242A GB201907242D0 GB 201907242 D0 GB201907242 D0 GB 201907242D0 GB 201907242 A GB201907242 A GB 201907242A GB 201907242 D0 GB201907242 D0 GB 201907242D0
Authority
GB
United Kingdom
Prior art keywords
dna methods
methods etc
dna
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1907242.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SNIPR Biome ApS
Original Assignee
SNIPR Biome ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SNIPR Biome ApS filed Critical SNIPR Biome ApS
Priority to GBGB1907242.0A priority Critical patent/GB201907242D0/en
Publication of GB201907242D0 publication Critical patent/GB201907242D0/en
Priority to CA3137804A priority patent/CA3137804A1/fr
Priority to JP2021569069A priority patent/JP2022542742A/ja
Priority to AU2020278898A priority patent/AU2020278898A1/en
Priority to SG11202111779PA priority patent/SG11202111779PA/en
Priority to PCT/EP2020/064225 priority patent/WO2020234428A1/fr
Priority to EP20727987.8A priority patent/EP3973052A1/fr
Priority to CN202080052941.3A priority patent/CN114144517A/zh
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10141—Use of virus, viral particle or viral elements as a vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10141—Use of virus, viral particle or viral elements as a vector
    • C12N2795/10142—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1907242.0A 2019-05-22 2019-05-22 Dna methods etc ii Ceased GB201907242D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB1907242.0A GB201907242D0 (en) 2019-05-22 2019-05-22 Dna methods etc ii
CA3137804A CA3137804A1 (fr) 2019-05-22 2020-05-21 Phage et particules de transduction
JP2021569069A JP2022542742A (ja) 2019-05-22 2020-05-21 ファージおよび形質導入粒子
AU2020278898A AU2020278898A1 (en) 2019-05-22 2020-05-21 Phage and transduction particles
SG11202111779PA SG11202111779PA (en) 2019-05-22 2020-05-21 Phage and transduction particles
PCT/EP2020/064225 WO2020234428A1 (fr) 2019-05-22 2020-05-21 Phage et particules de transduction
EP20727987.8A EP3973052A1 (fr) 2019-05-22 2020-05-21 Phage et particules de transduction
CN202080052941.3A CN114144517A (zh) 2019-05-22 2020-05-21 噬菌体和转导颗粒

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1907242.0A GB201907242D0 (en) 2019-05-22 2019-05-22 Dna methods etc ii

Publications (1)

Publication Number Publication Date
GB201907242D0 true GB201907242D0 (en) 2019-07-03

Family

ID=67385351

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1907242.0A Ceased GB201907242D0 (en) 2019-05-22 2019-05-22 Dna methods etc ii

Country Status (8)

Country Link
EP (1) EP3973052A1 (fr)
JP (1) JP2022542742A (fr)
CN (1) CN114144517A (fr)
AU (1) AU2020278898A1 (fr)
CA (1) CA3137804A1 (fr)
GB (1) GB201907242D0 (fr)
SG (1) SG11202111779PA (fr)
WO (1) WO2020234428A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112391357A (zh) * 2019-08-14 2021-02-23 宁波大学 温和气单胞菌高效裂解性噬菌体vB_AsoP-yong及其应用
CN114934059A (zh) * 2022-03-04 2022-08-23 深圳先进技术研究院 高通量简化噬菌体基因组骨架的方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115418324B (zh) * 2020-07-15 2023-09-01 北京工商大学 北工商梅泽氏菌新菌种及其应用
CN113046328B (zh) * 2021-04-13 2023-07-25 吉林大学 一株化脓隐秘杆菌噬菌体及其医用用途
WO2023056413A1 (fr) * 2021-09-30 2023-04-06 Board Of Regents, The University Of Texas System Vecteurs modifiés et organismes les contenant pour la conversion d'isoflavones dans l'intestin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070020240A1 (en) * 2003-10-06 2007-01-25 Gangagen, Inc. Defined dose therapeutic phage
US9676641B2 (en) * 2014-01-29 2017-06-13 Synphagen Llc Therapeutic phages and methods for delivery of nucleic acids for therapeutic uses
CN106687125B (zh) 2014-03-12 2021-12-14 耶达研究与开发有限公司 降低系统性调节性t细胞水平或活性来治疗cns疾病和损伤
WO2017009399A1 (fr) * 2015-07-13 2017-01-19 Institut Pasteur Amélioration des agents antimicrobiens spécifiques à une séquence par le blocage de la réparation de l'adn

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112391357A (zh) * 2019-08-14 2021-02-23 宁波大学 温和气单胞菌高效裂解性噬菌体vB_AsoP-yong及其应用
CN114934059A (zh) * 2022-03-04 2022-08-23 深圳先进技术研究院 高通量简化噬菌体基因组骨架的方法
CN114934059B (zh) * 2022-03-04 2023-02-21 深圳先进技术研究院 高通量简化噬菌体基因组骨架的方法

Also Published As

Publication number Publication date
EP3973052A1 (fr) 2022-03-30
AU2020278898A1 (en) 2021-12-16
CA3137804A1 (fr) 2020-11-26
WO2020234428A1 (fr) 2020-11-26
SG11202111779PA (en) 2021-12-30
CN114144517A (zh) 2022-03-04
JP2022542742A (ja) 2022-10-07

Similar Documents

Publication Publication Date Title
SG11202106666UA (en) Methods for rna analysis
ZA201905396B (en) Trans-replicating rna
SG11202003247RA (en) Rna sequence adaptation
IL288956A (en) RN" A building
EP3277380A4 (fr) Agents d'alkylation d'adn
GB201907242D0 (en) Dna methods etc ii
EP3508587A4 (fr) Procédé de séquençage d'adn
IL289589A (en) New methods
EP3619311C0 (fr) Assemblage d'adn
GB201812474D0 (en) Nucleic acid construct
GB201907882D0 (en) Methods
SG11202106810UA (en) Methods for targeted complementary dna enrichment
GB201913716D0 (en) Methods
GB201906705D0 (en) Methods
GB201908348D0 (en) Methods
GB201907157D0 (en) Methods
GB201913898D0 (en) Nucleic acid construct
GB201903909D0 (en) Methods
GB201901817D0 (en) Methods
SG11202009814VA (en) Dna construct design system
GB201704685D0 (en) Biological methods
GB201808063D0 (en) DNA, methods etc
GB201914729D0 (en) DNA marker
GB201911910D0 (en) Methods
GB201909704D0 (en) Methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)